SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018412
Filing Date
2023-11-09
Accepted
2023-11-09 07:10:47
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20230930x10q.htm   iXBRL 10-Q 1822292
2 EX-10.1 hook-20230930xex10d1.htm EX-10.1 78774
3 EX-31.1 hook-20230930xex31d1.htm EX-31.1 9858
4 EX-31.2 hook-20230930xex31d2.htm EX-31.2 9852
5 EX-32.1 hook-20230930xex32d1.htm EX-32.1 8477
  Complete submission text file 0001558370-23-018412.txt   7550531

Data Files

Seq Description Document Type Size
6 EX-101.SCH hook-20230930.xsd EX-101.SCH 58437
7 EX-101.CAL hook-20230930_cal.xml EX-101.CAL 49537
8 EX-101.DEF hook-20230930_def.xml EX-101.DEF 231830
9 EX-101.LAB hook-20230930_lab.xml EX-101.LAB 471537
10 EX-101.PRE hook-20230930_pre.xml EX-101.PRE 352834
66 EXTRACTED XBRL INSTANCE DOCUMENT hook-20230930x10q_htm.xml XML 1159686
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 231390030
SIC: 2834 Pharmaceutical Preparations